Stockscreener 앱 받기
16.93
6.61%
1.05
전일 마감가:
$15.88
열려 있는:
$15.71
하루 거래량:
2.48M
Relative Volume:
43.83
시가총액:
$4.75B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$15.67
$17.15
1주일 범위
$15.40
$17.15
52주 변동 폭
$15.40
$17.15
Medifast Inc Stock (MMED) Company Profile
명칭
Medifast Inc
전화
763-222-9423
주소
18000 DEVONSHIRE ST., NORTHRIDGE
Compare MMED vs ROL, SCI, HRB, FTDR, ANDG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MMED
Medifast Inc
|
16.93 | 4.46B | 0 | 0 | 0 | 0.00 |
ROL
Rollins Inc
|
45.11 | 21.89B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
78.72 | 10.99B | 4.33B | 535.79M | 486.05M | 3.79 |
HRB
H R Block Inc
|
42.08 | 5.30B | 3.91B | 736.10M | 760.88M | 5.6238 |
FTDR
Frontdoor Inc
|
75.69 | 5.33B | 2.12B | 260.00M | 385.00M | 3.5067 |
ANDG
Andersen Group Inc
|
44.45 | 4.83B | 871.37M | -163.01M | 0 | 1.0456 |
Medifast Inc 주식(MMED)의 최신 뉴스
Medifast launches Trilivy, replacing its Optavia brand - StreetInsider
Medifast rebrands weight loss program as Trilivy By Investing.com - Investing.com Nigeria
Medifast Gains on Trilivy Launch - Baystreet.ca
Medifast rebrands weight loss program as Trilivy - Investing.com India
Medifast Rebrands as Trilivy™: Launches Science-Backed Metabolic Health System for Optimal Wellness 6 - Minichart
Medifast (NYSE: MED) rebrands OPTAVIA as Trilivy metabolic health platform - Stock Titan
Medifast Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System - Business Wire
Medifast (NYSE:MED) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack - TradingView
Medifast Inc (NYSE: MED) director details indirect fund-held share ownership in Form 3/A - Stock Titan
Medifast Inc extends its weight-loss pivot as investors watch for the next strategic move - ad-hoc-news.de
Medifast Essential 4&2&1 Plan Kit from Medifast Inc.structured weight-loss bundle for US dieters - ad-hoc-news.de
3 Reasons MED is Risky and 1 Stock to Buy Instead - The Globe and Mail
Medifast Inc focus on weight-loss programs as industry shifts - ad-hoc-news.de
MEDIFAST Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesEPS Consistency Score - dars.gov.et
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value Benchmark - marketscreener.com
Price to sales forward of MEDIFAST INC – NYSE:MED - TradingView
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Defensive Index - marketscreener.com
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - ad-hoc-news.de
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
MEDIFAST INC (MED) Q1 2026 Earnings: EPS Surprises to the Upside Despite Net Loss; Stock GainsCost Structure Review - dars.gov.et
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast faces challenges with shrinking coach ... - Pluang
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - Yahoo Finance
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Medifast announces CEO succession plan, Johnson named president By Investing.com - Investing.com Nigeria
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026 - Business Wire
Law firm investigates Medifast directors for po... - Pluang
Medifast's New Product Pipeline: Key Catalyst for Comeback? - Yahoo Finance
Investment firm shakes up public company board - The Business Journals
Medifast Announces Cooperation Agreement with Steamboat Capital - Business Wire
Hims and Hers Expands Consumer-Focused Digital Health Platform - TradingView
Weight Loss and Diet Management Analysis Report 2026-2035: A $45+ Billion Market by 2030 with Weight Watchers, Nutrisystem, Kellogg, Herbalife, Apollo Endosurgery, and Medifast Leading - Yahoo Finance UK
Public company to leave Harbor East headquarters - The Business Journals
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Medifast Is A Net-Net With Negative Enterprise Value (NYSE:MED) - Seeking Alpha
Nicholas Johnson - Direct Selling News
Local public company looks beyond weight loss amid revenue decline - The Business Journals
Medifast Stock: Between Obsolescence And Optionality (NYSE:MED) - Seeking Alpha
Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y - Yahoo Finance
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™ - Business Wire
With 78% ownership of the shares, Medifast, Inc. (NYSE:MED) is heavily dominated by institutional owners - Yahoo Finance
Medifast's sales plummeted 60% in 3 years. Is Ozempic to blame? - The Business Journals
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Business Wire
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off - Business Wire
Medifast pivots again as revenue falls by 43% - The Business Journals
Medifast to close Maryland warehouse, lay off 62 workers - The Business Journals
Medifast Inc (MMED) 재무 분석
Medifast Inc (MMED)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.83%
0.20%
자본화:
|
볼륨(24시간):